Anti-cancer effects of REIC/Dkk-3-encoding adenoviral vector for the treatment of non-small cell lung cancer

PLoS ONE

Volumn 9, Issue 2, 2014, Pages

  Shien, Kazuhiko ^a   Tanaka, Norimitsu ^a   Watanabe, Masami ^a,b,c   Soh, Junichi ^a   Sakaguchi, Masakiyo ^a   Matsuo, Keitaro ^d   Yamamoto, Hiromasa ^a   Furukawa, Masashi ^a   Asano, Hiroaki ^a   Tsukuda, Kazunori ^a   Nasu, Yasutomo ^a   Huh, Nam Ho ^a   Miyoshi, Shinichiro ^a   Kumon, Hiromi ^a,c   Toyooka, Shinichi ^a  

^a OKAYAMA UNIVERSITY   (Japan)

^b OKAYAMA UNIVERSITY HOSPITAL   (Japan)

^c OKAYAMA UNIVERSITY   (Japan)

^d KYUSHU UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOVIRUS VECTOR; COXSACKIE VIRUS AND ADENOVIRUS RECEPTOR; DICKKOPF 3 PROTEIN; GLUCOSE REGULATED PROTEIN 78; STRESS ACTIVATED PROTEIN KINASE; TUMOR SUPPRESSOR PROTEIN; UNCLASSIFIED DRUG;

ADULT; ANIMAL EXPERIMENT; ANIMAL MODEL; APOPTOSIS; ARTICLE; CANCER CELL; CANCER GENE THERAPY; CANCER INHIBITION; CELL VIABILITY; CONTROLLED STUDY; ENDOPLASMIC RETICULUM STRESS; FEMALE; HUMAN; HUMAN CELL; LUNG NON SMALL CELL CANCER; MOUSE; NONHUMAN; TUMOR XENOGRAFT; UPREGULATION; VIRAL GENE THERAPY;

ADENOCARCINOMA; ADENOVIRIDAE; ANIMALS; APOPTOSIS; BLOTTING, WESTERN; CARCINOMA, NON-SMALL-CELL LUNG; CARCINOMA, SQUAMOUS CELL; CELL PROLIFERATION; FEMALE; FLOW CYTOMETRY; GENETIC VECTORS; HUMANS; INTERCELLULAR SIGNALING PEPTIDES AND PROTEINS; LUNG NEOPLASMS; MICE; MICE, INBRED BALB C; MICE, NUDE; TUMOR CELLS, CULTURED; XENOGRAFT MODEL ANTITUMOR ASSAYS;

EID: 84896897551     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0087900     Document Type: Article

References (25)

1. Jemal A, Siegel R, Ward E, Hao Y, Xu J, et al. (2009) Cancer statistics, 2009. CA Cancer J Clin 59: 225-249.
2. Larsen JE, Cascone T, Gerber DE, Heymach JV, Minna JD (2011) Targeted therapies for lung cancer: clinical experience and novel agents. Cancer J 17: 512-527.
3. Shigematsu H, Lin L, Takahashi T, Nomura M, Suzuki M, et al. (2005) Clinical and biological features associated with epidermal growth factor receptor gene mutations in lung cancers. J Natl Cancer Inst 97: 339-346. (Pubitemid 40425952)
4. Tokumo M, Toyooka S, Kiura K, Shigematsu H, Tomii K, et al. (2005) The relationship between epidermal growth factor receptor mutations and clinico-pathologic features in non-small cell lung cancers. Clin Cancer Res.
5. Kwak EL, Bang YJ, Camidge DR, Shaw AT, Solomon B, et al. (2010) Anaplastic lymphoma kinase inhibition in non-small-cell lung cancer. N Engl J Med 363: 1693-1703.
6. Shaw AT, Yeap BY, Solomon BJ, Riely GJ, Gainor J, et al. (2011) Effect of crizotinib on overall survival in patients with advanced non-small-cell lung cancer harbouring ALK gene rearrangement: a retrospective analysis. Lancet Oncol 12: 1004-1012.
7. Oxnard GR, Janjigian YY, Arcila ME, Sima CS, Kass SL, et al. (2011) Maintained sensitivity to EGFR tyrosine kinase inhibitors in EGFR-mutant lung cancer recurring after adjuvant erlotinib or gefitinib. Clin Cancer Res 17: 6322-6328.
8. Tsuji T, Miyazaki M, Sakaguchi M, Inoue Y, Namba M (2000) A REIC gene shows down-regulation in human immortalized cells and human tumor-derived cell lines. Biochem Biophys Res Commun 268: 20-24. (Pubitemid 30116603)
9. Krupnik VE, Sharp JD, Jiang C, Robison K, Chickering TW, et al. (1999) Functional and structural diversity of the human Dickkopf gene family. Gene 238: 301-313. (Pubitemid 29447031)
10. Mao B, Wu W, Davidson G, Marhold J, Li M, et al. (2002) Kremen proteins are Dickkopf receptors that regulate Wnt/beta-catenin signalling. Nature 417: 664-667. (Pubitemid 34614827)
11. Abarzua F, Sakaguchi M, Takaishi M, Nasu Y, Kurose K, et al. (2005) Adenovirus-mediated overexpression of REIC/Dkk-3 selectively induces apoptosis in human prostate cancer cells through activation of c-Jun-NH2-kinase. Cancer Res 65: 9617-9622. (Pubitemid 41541434)
12. Edamura K, Nasu Y, Takaishi M, Kobayashi T, Abarzua F, et al. (2007) Adenovirus-mediated REIC/Dkk-3 gene transfer inhibits tumor growth and metastasis in an orthotopic prostate cancer model. Cancer Gene Ther 14: 765-772. (Pubitemid 47262756)
13. Tanimoto R, Abarzua F, Sakaguchi M, Takaishi M, Nasu Y, et al. (2007) REIC/Dkk-3 as a potential gene therapeutic agent against human testicular cancer. Int J Mol Med 19: 363-368.
14. Kashiwakura Y, Ochiai K, Watanabe M, Abarzua F, Sakaguchi M, et al. (2008) Down-regulation of inhibition of differentiation-1 via activation of activating transcription factor 3 and Smad regulates REIC/Dickkopf-3-induced apoptosis. Cancer Res 68: 8333-8341.
15. Kawasaki K, Watanabe M, Sakaguchi M, Ogasawara Y, Ochiai K, et al. (2009) REIC/Dkk-3 overexpression downregulates P-glycoprotein in multidrug-resistant MCF7/ADR cells and induces apoptosis in breast cancer. Cancer Gene Ther 16: 65-72.
16. Watanabe M, Kashiwakura Y, Huang P, Ochiai K, Futami J, et al. (2009) Immunological aspects of REIC/Dkk-3 in monocyte differentiation and tumor regression. Int J Oncol 34: 657-663.
17. Shien K, Toyooka S, Yamamoto H, Soh J, Jida M, et al. (2013) Acquired Resistance to EGFR Inhibitors Is Associated with a Manifestation of Stem Cell-like Properties in Cancer Cells. Cancer Res 73: 3051-3061.
18. Kobayashi N, Toyooka S, Soh J, Yamamoto H, Dote H, et al. (2012) The anti-proliferative effect of heat shock protein 90 inhibitor, 17-DMAG, on non-smallcell lung cancers being resistant to EGFR tyrosine kinase inhibitor. Lung Cancer 75: 161-166.
19. Bai L, Mihara K, Kondo Y, Honma M, Namba M (1993) Immortalization of normal human fibroblasts by treatment with 4-nitroquinoline 1-oxide. Int J Cancer 53: 451-456. (Pubitemid 23047894)
20. Sakaguchi M, Kataoka K, Abarzua F, Tanimoto R, Watanabe M, et al. (2009) Overexpression of REIC/Dkk-3 in normal fibroblasts suppresses tumor growth via induction of interleukin-7. J Biol Chem 284: 14236-14244.
21. Kaufman RJ (2002) Orchestrating the unfolded protein response in health and disease. J Clin Invest 110: 1389-1398.
22. Li J, Lee AS (2006) Stress induction of GRP78/BiP and its role in cancer. Curr Mol Med 6: 45-54.
23. Sugimoto M, Watanabe M, Kaku H, Li SA, Noguchi H, et al. (2012) Preclinical biodistribution and safety study of reduced expression in immortalized cells/Dickkopf-3-encoding adenoviral vector for prostate cancer gene therapy. Oncol Rep 28: 1645-1652.
24. Sterman DH, Recio A, Carroll RG, Gillespie CT, Haas A, et al. (2007) A phase I clinical trial of single-dose intrapleural IFN-beta gene transfer for malignant pleural mesothelioma and metastatic pleural effusions: high rate of antitumor immune responses. Clin Cancer Res 13: 4456-4466. (Pubitemid 47219714)
25. Sterman DH, Recio A, Haas AR, Vachani A, Katz SI, et al. (2010) A phase I trial of repeated intrapleural adenoviral-mediated interferon-beta gene transfer for mesothelioma and metastatic pleural effusions. Mol Ther 18: 852-860.